In addition, serological studies by us and others have reported higher serum level of bone specific alkaline phosphatase (bALP), nuclear factor kappa-B ligand (RANKL) and tartrate-resistant acid phosphatase 5b (TRAP5b) in AIS patient7, 8, 9. This evidence concerns the gene TNFSF11 and androgen insensitivity syndrome.